Advertisement

Loading...

TripSitter Clinic Ltd.

KETA.CNCNQ
Healthcare
Medical - Healthcare Information Services
$0.08
$0.005(6.67%)
Canadian Market opens in 7h 0m

TripSitter Clinic Ltd. Fundamental Analysis

TripSitter Clinic Ltd. (KETA.CN) shows weak financial fundamentals with a PE ratio of -114.77, profit margin of 0.00%, and ROE of 0.59%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-9.18

Areas of Concern

ROE0.59%
Operating Margin0.00%
Cash Position0.11%
Current Ratio0.00
We analyze KETA.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 31.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
31.7/100

We analyze KETA.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

KETA.CN struggles to generate sufficient returns from assets.

ROA > 10%
-7.76%

Valuation Score

Excellent

KETA.CN trades at attractive valuation levels.

PE < 25
-114.77
PEG Ratio < 2
-9.18

Growth Score

Weak

KETA.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

KETA.CN shows balanced financial health with some risks.

Debt/Equity < 1
-0.48
Current Ratio > 1
0.00

Profitability Score

Weak

KETA.CN struggles to sustain strong margins.

ROE > 15%
59.36%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is KETA.CN Expensive or Cheap?

P/E Ratio

KETA.CN trades at -114.77 times earnings. This suggests potential undervaluation.

-114.77

PEG Ratio

When adjusting for growth, KETA.CN's PEG of -9.18 indicates potential undervaluation.

-9.18

Price to Book

The market values TripSitter Clinic Ltd. at -0.65 times its book value. This may indicate undervaluation.

-0.65

EV/EBITDA

Enterprise value stands at -31.06 times EBITDA. This is generally considered low.

-31.06

How Well Does KETA.CN Make Money?

Net Profit Margin

For every $100 in sales, TripSitter Clinic Ltd. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $0.59 in profit for every $100 of shareholder equity.

0.59%

ROA

TripSitter Clinic Ltd. generates $-7.76 in profit for every $100 in assets, demonstrating efficient asset deployment.

-7.76%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

KETA.CN converts -10.36% of its market value into free cash.

-10.36%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-114.77

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-9.18

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.65

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.48

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.001

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.006

vs 25 benchmark

ROA

Return on assets percentage

-7.76

vs 25 benchmark

ROCE

Return on capital employed

0.17

vs 25 benchmark

How KETA.CN Stacks Against Its Sector Peers

MetricKETA.CN ValueSector AveragePerformance
P/E Ratio-114.7728.31 Better (Cheaper)
ROE0.59%699.00% Weak
Net Margin0.00%-130884.00% (disorted) Weak
Debt/Equity-0.480.34 Strong (Low Leverage)
Current Ratio0.002775.16 Weak Liquidity
ROA-776.09%-14469.00% (disorted) Weak

KETA.CN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews TripSitter Clinic Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ